Press Releases

Date Title and Summary Additional Formats
Toggle Summary Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6th, 2020
RANCHO CUCAMONGA, Calif. , July 30, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its second quarter of 2020 ended June 30, 2020 , after the market closes on Thursday, August 6th, 2020 , and will hold a conference call to
View HTML
Toggle Summary Amphastar Pharmaceuticals to Present at the BMO Prescriptions for Success Healthcare Conference
RANCHO CUCAMONGA, Calif. , June 19, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters , CFO, Dan Dischner , Vice President of Corporate Communications and Human Resources, and Tony Marrs , Sr. Vice President Regulatory Affairs and Clinical
View HTML
Toggle Summary Amphastar Pharmaceuticals to Present at the Raymond James Virtual 2020 Human Healthcare Innovation Conference
RANCHO CUCAMONGA, Calif. , June 12, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters , CFO, Dan Dischner , Vice President of Corporate Communications and Human Resources, and Tony Marrs , Sr. Vice President Regulatory Affairs and Clinical
View HTML
Toggle Summary Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Succinylcholine Chloride Injection USP, 200 mg/10 mL (20 mg/mL) Multiple-Dose Vial
RANCHO CUCAMONGA, Calif. , June 09, 2020 (GLOBE NEWSWIRE) -- Amphastar ®   Pharmaceuticals, Inc. , (NASDAQ: AMPH) (“Amphastar”), today announces that the U.S. Food and Drug Administration (“FDA”) has approved its Abbreviated New Drug Application (“ANDA”) for Succinylcholine Chloride Injection USP,
View HTML
Toggle Summary Amphastar Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
RANCHO CUCAMONGA, Calif. , June 02, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters , CFO and Dan Dischner , Vice President of Corporate Communications and Human Resources will be presenting at the Jefferies Virtual Healthcare Conference on
View HTML
Toggle Summary Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2020
Reports Net Revenues of $84.7 Million for the Three Months Ended March 31, 2020 RANCHO CUCAMONGA, Calif. , May 07, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (“Amphastar” or the “Company”) today reported results for the three months ended March 31, 2020 .
View HTML
Toggle Summary Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7th, 2020
RANCHO CUCAMONGA, Calif. , May 04, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its first quarter of 2020 ended March 31, 2020 , after the market closes on Thursday, May 7th, 2020 , and will hold a conference call to
View HTML
Toggle Summary Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose Vial
RANCHO CUCAMONGA, Calif. , April 27, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. , (NASDAQ: AMPH) (“Amphastar”),  today announces that the U.S. Food and Drug Administration (“FDA”) has granted approval of its Abbreviated New Drug Application (“ANDA”) for Epinephrine Injection, USP
View HTML
Toggle Summary Amphastar Pharmaceuticals, Inc. Announces Simplification of Management Structure
RANCHO CUCAMONGA, Calif. , April 13, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (“Amphastar” or the “Company”), a California -based, specialty, generic pharmaceutical company, today announces a recent simplification of the Company’s management by removing a layer of
View HTML
Toggle Summary Amphastar Pharmaceuticals to Present at the 19th Annual Needham Virtual Healthcare Conference
RANCHO CUCAMONGA , April 09, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Jason Shandell , President and Bill Peters , CFO will be presenting at the 19 th Annual Needham Virtual Healthcare Conference on Wednesday, April 15, 2020 at 12:50 p.m.
View HTML

 

Copyright ©2020 Amphastar Pharmaceuticals, Inc.

Privacy      Terms & Conditions

This site is intended for residents of the United States